Medicare Enrolled
Dr. Paul Yonover, MD
Urology Physician · Chicago, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yonover from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yonover?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yonover
Dr. Paul Yonover is an urology physician in Chicago, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yonover performed 3,124 Medicare services across 1,325 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yonover received a total of $107,110 from 67 pharmaceutical and/or device companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yonover is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in IL
$107,110 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,124
Medicare services
Top 30% in IL for urology physician
1,325
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~156 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 924 | $68 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
429 | $93 | $226 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
285 | $68 | $162 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
261 | $8 | $20 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
259 | $46 | $129 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
179 | $8 | $100 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
156 | $2 | $20 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
118 | $5 | $40 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
98 | $10 | $240 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
79 | $97 | $550 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
74 | $40 | $154 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
60 | $195 | $930 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
44 | $68 | $177 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $151 | $324 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $128 | $302 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
28 | $29 | $160 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $85 | $200 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $107 | $590 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
11 | $26 | $560 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
11 | $232 | $1,240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$107,110
Total received (2018-2024)
Avg $15,301/year across 7 years
Top 3% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
431
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48,258 (45.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$48,242 (45.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,610 (9.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$12,620
2023
$18,951
2022
$2,609
2021
$2,190
2020
$10,526
2019
$35,990
2018
$24,224
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Telix Pharmaceuticals
$9,094
ACCORD HEALTHCARE, INC.
$1,095
PFIZER INC.
$1,009
ABBVIE INC.
$227
Janssen Biotech, Inc.
$179
PROGENICS PHARMACEUTICALS, INC.
$124
Dendreon Pharmaceuticals LLC
$104
Astellas Pharma US Inc
$100
Blue Earth Diagnostics Limited
$86
Merck Sharp & Dohme LLC
$71
PROCEPT BioRobotics Corporation
$57
Tempus AI, Inc
$57
Sumitomo Pharma America, Inc.
$54
AstraZeneca Pharmaceuticals LP
$51
COLOPLAST CORP
$51
Novartis Pharmaceuticals Corporation
$40
Verity Pharmaceuticals Inc.
$38
Ferring Pharmaceuticals Inc.
$35
Boston Scientific Corporation
$27
Laborie Medical Technologies Corp.
$27
LANTHEUS MEDICAL IMAGING, INC.
$27
Myriad Genetic Laboratories, Inc.
$24
IMMUNITYBIO, INC.
$23
180 Medical, Inc.
$22
Top 3 companies account for 88.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$29,948
Telix Pharmaceuticals
$14,995
Augmenix, Inc.
$14,375
PFIZER INC.
$11,252
ACCORD HEALTHCARE, INC.
$11,155
AUGMENIX, INC.
$6,559
Pfizer Inc.
$3,913
Clovis Oncology, Inc.
$2,509
Bayer HealthCare Pharmaceuticals Inc.
$2,339
Progenics Pharmaceuticals, Inc.
$2,222
Blue Earth Diagnostics Limited
$1,212
Janssen Scientific Affairs, LLC
$794
Janssen Biotech, Inc.
$775
Medivators Inc.
$500
Boston Scientific Corporation
$363
ABBVIE INC.
$305
Dendreon Pharmaceuticals LLC
$268
Olympus America Inc.
$217
AbbVie, Inc.
$211
AbbVie Inc.
$202
Coloplast Corp
$172
UroGPO LLC
$166
AstraZeneca Pharmaceuticals LP
$165
TOLMAR Pharmaceuticals, Inc.
$164
Verity Pharmaceuticals Inc.
$164
Sumitomo Pharma America, Inc.
$162
Merck Sharp & Dohme LLC
$151
PROGENICS PHARMACEUTICALS, INC.
$124
C. R. Bard, Inc. & Subsidiaries
$113
MEDIVATION FIELD SOLUTIONS LLC
$111
Accord Healthcare, Inc.
$106
PROCEPT BioRobotics Corporation
$91
Endo Pharmaceuticals Inc.
$84
Ferring Pharmaceuticals Inc.
$82
Medtronic, Inc.
$75
Laborie Medical Technologies Corp.
$72
Antares Pharma, Inc.
$68
COLOPLAST CORP
$62
Allergan, Inc.
$57
Tempus AI, Inc
$57
Teleflex LLC
$50
180 Medical, Inc.
$50
Avadel Specialty Pharmaceuticals, LLC
$49
UroViu Corporation
$47
UROVANT SCIENCES INC
$45
Myriad Genetic Laboratories, Inc.
$41
Novartis Pharmaceuticals Corporation
$40
NxThera, Inc.
$36
DENTSPLY IH Inc.
$30
Kowa Pharmaceuticals America, Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$27
LANTHEUS MEDICAL IMAGING, INC.
$27
PALETTE LIFE SCIENCES, INC.
$26
Smith+Nephew, Inc.
$25
IMMUNITYBIO, INC.
$23
Terumo Medical Corporation
$23
Retrophin, Inc.
$22
Amgen Inc.
$21
Janssen Pharmaceuticals, Inc
$20
Cook Medical LLC
$18
NeoTract Inc.
$18
Allergan Inc.
$17
Aytu BioScience, Inc
$16
Medtronic USA, Inc.
$15
Merck Sharp & Dohme Corporation
$14
SRS Medical Systems, Inc.
$13
Metuchen Pharmaceuticals
$13
Top 3 companies account for 55.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS 700 · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axumin · BAGLEY · BOTOX · BRIDION · CAMCEVI · COOK · CYSTO-NEPHRO VIDEOSCOPE · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENTLECATH · GENTLECATH GLIDE · HydroPearl · ILLUCCIX · INTERSTIM · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MIRABEGRON · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · NURO · Natesto · Noctiva · Nubeqa · OES CYSTONEPHROFIBERSCOPE · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Padcev · Prolia · RUBRACA · Rezum · SEGLENTIS · SPEEDICATH · SUTENT · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · Stravix · TALZENNA · TITAN · Titan · Trelstar · UROLIFT · Uro-G Flexible Cystoscope · UroCuff · UroLift · UroLift System · VESICARE · VISERA ELITE · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (45%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for urology physician in IL.
Geographic Context
Urology physicians within 10 mi
324
Per 100K population
6.2
County median income
$81,797
Nearest hospital
ADVOCATE ILLINOIS MASONIC MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yonover is a clinical cardiology specialist, with above-average Medicare volume (top 30% in IL), with speaking/promotional industry engagement in the top 3% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yonover experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Yonover performed 924 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yonover receive payments from pharmaceutical companies?
Yes. Dr. Yonover received a total of $107,110 from 67 companies across 431 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yonover's costs compare to other urology physicians in Chicago?
Dr. Yonover's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yonover) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Chicago
Browse urology physicians in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Telix Pharmaceuticals Payments to Doctors
See all physicians who received payments from Telix Pharmaceuticals.
By company
Augmenix, Inc. Payments to Doctors
See all physicians who received payments from Augmenix, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology